Compare Novavax Inc (NVAX) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Under Armour Inc Class A — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Under Armour Inc Class A trades at $7.18 (market cap $3.07B). The key difference: Under Armour Inc Class A is far larger — about 2.4× Novavax Inc's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | UA | |
|---|---|---|
Market Cap | $1.30B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $7.88 |
52-Week Low | $6.22 | $3.96 |
Enterprise Value | $800.50M | $4.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
